Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06470893 · ClinicalTrials.gov registry record · NA

Online Exposure Therapy for Obsessive-Compulsive Disorder (OCD) Study

A NA study of Obsessive - Compulsive Disorder, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
63
Enrollment target
1
Study location

NCT06470893 is a NA study of Obsessive - Compulsive Disorder that has completed, run by University of Miami. The registered enrollment target is 63 participants, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06470893, a NA study of Obsessive - Compulsive Disorder, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
63 participants
Enrollment target
1
Study location

Study Summary

The overarching goal of this protocol is to investigate mechanisms that influence symptom outcomes of exposure and response prevention (ERP) therapy for OCD. Mechanisms may include affective processes, learning factors, cognitive factors, or other constructs that could influence treatment outcomes. The study team will conduct this research within the context of an effective online treatment for OCD called OCD-NET. OCD-NET is bibliotherapy with coaching and its content is reflective of standard care for OCD.

Interventions

  • BEHAVIORAL OCD-NET

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2024-09-23
Est. Completion 2025-07-23
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT06470893

The ClinicalTrials.gov registry entry for NCT06470893 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (97% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 1 intervention - of which OCD-NET is the first listed.

NCT06470893 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06470893 about?

NCT06470893 is a clinical study titled "Online Exposure Therapy for Obsessive-Compulsive Disorder (OCD) Study". The overarching goal of this protocol is to investigate mechanisms that influence symptom outcomes of exposure and response prevention (ERP) therapy for OCD. Mechanisms may include affective processes, learning factors, cognitive factors, or other constructs that could influence treatment outcomes. ...

What is the current status of trial NCT06470893?

This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2024-09-23. Estimated completion is 2025-07-23.

What conditions does trial NCT06470893 study?

This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.

What interventions are being tested in trial NCT06470893?

The interventions under investigation include: OCD-NET (BEHAVIORAL).

Who is sponsoring clinical trial NCT06470893?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06470893 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obsessive - Compulsive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.